XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
1.250
-0.010 (-0.79%)
Nov 21, 2024, 11:32 AM EST - Market open
XORTX Therapeutics Employees
As of December 31, 2023, XORTX Therapeutics had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$245,552
Market Cap
4.33M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 0 | - |
| Jan 1, 2022 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Check-Cap | 85 |
| Biofrontera | 85 |
| iSpecimen | 53 |
| Sunshine Biopharma | 44 |
| Predictive Oncology | 35 |
| Windtree Therapeutics | 20 |
| Galmed Pharmaceuticals | 8 |
| Pasithea Therapeutics | 8 |
XRTX News
- 4 weeks ago - XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement - GlobeNewsWire
- 6 weeks ago - XORTX Initiates Precision Medicine Program - GlobeNewsWire
- 2 months ago - XORTX Announces Results of Annual and Special Meeting of Shareholders - GlobeNewsWire
- 2 months ago - XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A - GlobeNewsWire
- 2 months ago - XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders - GlobeNewsWire
- 2 months ago - Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders - GlobeNewsWire
- 3 months ago - XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders - GlobeNewsWire
- 3 months ago - XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024 - GlobeNewsWire